Cargando…
Impact of two‑field or three‑field lymphadenectomy on overall survival in middle and lower thoracic esophageal squamous cell carcinoma: A single‑center retrospective analysis
Squamous cell carcinoma is the main subtype of esophageal cancer in East Asia. The effect of the number of lymph nodes (LNs) removed to treat middle and lower thoracic esophageal squamous cell carcinoma (ESCC) in China remains controversial. Therefore, the present study aimed to investigate the impa...
Autores principales: | Li, Kexun, Du, Kunyi, Liu, Kun, Nie, Xin, Li, Changding, He, Wenwu, Li, Kunzhi, Wang, Chenghao, Li, Zhiyu, Zheng, Kai, Mao, Tianqin, Jiang, Longlin, Li, Haojun, Miao, Yan, Xie, Qin, Fang, Qiang, Han, Yongtao, Leng, Xuefeng, Peng, Lin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10091183/ https://www.ncbi.nlm.nih.gov/pubmed/37065785 http://dx.doi.org/10.3892/ol.2023.13774 |
Ejemplares similares
-
Resected lymph nodes and survival of patients with esophageal squamous cell carcinoma: an observational study
por: Li, Kexun, et al.
Publicado: (2023) -
The efficacy and safety of neoadjuvant immunotherapy in resectable locally advanced esophageal squamous cell carcinoma: A systematic review and meta-analysis
por: He, Wenwu, et al.
Publicado: (2023) -
Tislelizumab Plus Chemotherapy Sequential Neoadjuvant Therapy for Non-cCR Patients After Neoadjuvant Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma (ETNT): An Exploratory Study
por: He, Wenwu, et al.
Publicado: (2022) -
Past, present, and future of three‐field lymphadenectomy for thoracic esophageal cancer
por: Udagawa, Harushi
Publicado: (2020) -
The impact of adjuvant therapy on survival for node-negative esophageal squamous cell carcinoma: a propensity score-matched analysis
por: Deng, Xuyang, et al.
Publicado: (2021)